Pharmaceutical giant Novo Nordisk (NYSE: NVO) released its fourth-quarter and full-year earnings report on Feb. 5. The Denmark-based company performed pretty well, leading to a post-earnings jump in ...

Yo-yo dieter Bev Thomas, 53, from Port Talbot, Wales, lost six stone in six months on weight loss drug Mounjaro after her ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs. Net profit for the fourth ...

Share on Pinterest LeoPatrizi/Getty Images Semaglutide is the active ingredient in Wegovy, Ozempic, and Rybelsus. Currently, only Wegovy is approved for weight loss in the United States.

The General Pharmaceutical Council (GPhC) has introduced new rules for weight-loss jabs, such as Wegovy and Mounjaro, in response to concerns over their misuse. The GPhC has tightened prescription ...

One jab, Wegovy, is already available to some people and a second, Mounjaro, will soon be available - although it could be more than a decade before it is fully rolled-out. NHS experts have warned ...

Demand for weight loss jabs continues to surge and has been spurred on by the NHS offering Wegovy to patients and will start offering Mounjaro in March 2025. They have also become increasingly popular ...

Wegovy, to shame. Let's look deeper into these results and what they could mean for investors. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free ...

Often up before the sun to get his workout in before heading to work as weatherman and co-host of TODAY, Al Roker knows the importance of a filling, energizing breakfast. And he shared with ...

When you choose what to eat for breakfast, you are (whether you know it or not) deciding how easy it will be to stick to your diet throughout the day, says Mark Gilbert, a nutritionist for the 1:1 ...